2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Hepatocellular
222
Carcinoma, Renal Cell
84
Liver Neoplasms
68
Neoplasms
53
Leukemia, Myeloid, Acute
37
Neoplasm Metastasis
34
Carcinoma, Non-Small-Cell Lung
33
Breast Neoplasms
29
Melanoma
24
Kidney Neoplasms
22
Pancreatic Neoplasms
16
Brain Neoplasms
15
Sarcoma
14
Prostatic Neoplasms
14
Lung Neoplasms
14
Thyroid Neoplasms
13
Recurrence
13
Glioblastoma
13
Colorectal Neoplasms
12
Carcinoma
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Urinary Bladder Neoplasms
8
Rectal Neoplasms
8
Ovarian Neoplasms
8
Myelodysplastic Syndromes
8
Multiple Myeloma
8
Gliosarcoma
8
Stomach Neoplasms
7
Colonic Neoplasms
7
Unspecified Adult Solid Tumor, Protocol Specific
6
Interventions
Etoposide
30
Carboplatin
30
Cisplatin
23
Ifosfamide
22
Filgrastim
22
Paclitaxel
18
Peripheral Blood Stem Cell Transplantation
16
Bleomycin
13
Cyclophosphamide
11
Radiotherapy
8
Thiotepa
7
Magnetic Resonance Spectroscopy
6
Gemcitabine
6
pegfilgrastim
5
Therapeutics
5
Polymerase Chain Reaction
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
Flow Cytometry
5
Busulfan
5
etoposide phosphate
4
Temozolomide
4
Psychiatric Rehabilitation
4
Oxaliplatin
4
Dexamethasone
4
sargramostim
3
Vinblastine
3
Taxes
3
Surveys and Questionnaires
3
Methylprednisolone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Testicular Neoplasms
×
Sorafenib
×
Clear all
NCT00772694
2008-10-24
GCT
Fondation Wygrajmy Zdrowie
Phase 2
Unknown
20 enrolled